Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
4
×
amgen
4
×
biotech
clinical trials
eli lilly
fda
4
×
life sciences
national
national blog main
national top stories
new york blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biohaven
bristol-myers squibb
genentech
glaxosmithkline
ipo
medical device
migraine
What
drugs
fda
bio
class
migraine
new
roundup
won
adults
allergan
appetite
approval
approved
arguments
august
big
biotech
black
bread
busy
butter
buyout
cancer
cash
commercialized
companies
competitors
days
decades
decisions
devices
diabetes
diamond’s
drug
eli
giant
grabbed
hasn’t
hold
legacy
Language
unset
Current search:
allergan
×
fda
×
amgen
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More